An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMC 1211538)

Published in J Virol on October 01, 2005

Authors

Tao Pan1, Binggong Chang, Poki Wong, Chaoyang Li, Ruliang Li, Shin-Chung Kang, John D Robinson, Andrew R Thompsett, Po Tein, Shaoman Yin, Geoff Barnard, Ian McConnell, David R Brown, Thomas Wisniewski, Man-Sun Sy

Author Affiliations

1: Institute of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44107-1712, USA.

Articles citing this

Generating a prion with bacterially expressed recombinant prion protein. Science (2010) 6.26

A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95

Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans. Proc Natl Acad Sci U S A (2007) 1.02

Phage display mediated immuno-PCR. Nucleic Acids Res (2006) 0.94

Aggregation of prion protein with insertion mutations is proportional to the number of inserts. Biochem J (2007) 0.90

Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation. PLoS One (2013) 0.84

Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clin Vaccine Immunol (2006) 0.82

Ligand binding promotes prion protein aggregation--role of the octapeptide repeats. FEBS J (2008) 0.82

Generating Bona Fide Mammalian Prions with Internal Deletions. J Virol (2016) 0.81

Diphenylpyrazole-derived compounds increase survival time of mice after prion infection. Antimicrob Agents Chemother (2011) 0.79

Identification of misfolded proteins in body fluids for the diagnosis of prion diseases. Int J Cell Biol (2013) 0.76

Highly polar environments catalyze the unfolding of PrP C helix 1. Eur Biophys J (2010) 0.76

TSE diagnostics: recent advances in immunoassaying prions. Clin Dev Immunol (2013) 0.75

The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules. Front Mol Neurosci (2017) 0.75

Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains. Oncotarget (2017) 0.75

Articles cited by this

Prions. Proc Natl Acad Sci U S A (1998) 27.80

Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36

Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01

Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92

Identification of a protein that purifies with the scrapie prion. Science (1982) 7.00

Self-replication and scrapie. Nature (1967) 6.01

A prion protein epitope selective for the pathologically misfolded conformation. Nat Med (2003) 3.41

A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol (1997) 2.95

Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem (1993) 2.59

Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A (2001) 2.53

Pathologic conformations of prion proteins. Annu Rev Biochem (1998) 2.50

Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry (2002) 2.36

Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol (2001) 2.19

Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol (1999) 1.90

pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J Biol Chem (1997) 1.85

Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology (1988) 1.85

Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science (2001) 1.82

Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80

Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol (1995) 1.68

Separation of scrapie prion infectivity from PrP amyloid polymers. J Mol Biol (1996) 1.52

Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44

Molecular characteristics of prion rods purified from scrapie-infected hamster brains. J Infect Dis (1986) 1.37

Protein misfolding and prion diseases. J Mol Biol (1999) 1.37

Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates. Proc Natl Acad Sci U S A (1999) 1.19

Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation. J Biol Chem (2003) 1.18

A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J Biol Chem (1995) 1.15

The role of helix 1 aspartates and salt bridges in the stability and conversion of prion protein. J Biol Chem (2003) 1.14

Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue. J Biol Chem (2003) 1.09

Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J Biol Chem (2000) 1.09

Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci Lett (2003) 1.09

On-column purification and refolding of recombinant bovine prion protein: using its octarepeat sequences as a natural affinity tag. Protein Expr Purif (2003) 1.06

A monomer-dimer equilibrium of a cellular prion protein (PrPC) not observed with recombinant PrP. J Biol Chem (2000) 1.05

The role of dimerization in prion replication. Biophys J (2002) 1.02

Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J Biol Chem (2001) 1.01

Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J Virol (2005) 0.95

Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties. Biochemistry (2001) 0.90

Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. J Neurochem (2004) 0.89

Structures of prion proteins and conformational models for prion diseases. Curr Top Microbiol Immunol (1996) 0.87

Factors affecting interactions between prion protein isoforms. Biochem Soc Trans (2002) 0.78

Functional and structural differences between the prion protein from two alleles prnp(a) and prnp(b) of mouse. Eur J Biochem (2000) 0.77

Articles by these authors

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care (2008) 10.90

A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J (2002) 3.87

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77

Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75

Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr (2007) 3.64

An inhibitor of FtsZ with potent and selective anti-staphylococcal activity. Science (2008) 3.21

A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95

Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci (2012) 2.92

Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J Neurosci (2008) 2.77

Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol (2010) 2.67

Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care (2008) 2.66

Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation (2007) 2.58

Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci (2005) 2.46

The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol (2010) 2.42

Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes (2010) 2.39

Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol (2008) 2.33

Metabolic syndrome and health-related quality of life among U.S. adults. Ann Epidemiol (2008) 2.21

Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med (2009) 2.17

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging (2009) 2.15

Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol (2004) 2.11

Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr (2007) 2.11

Transgenic malaria-resistant mosquitoes have a fitness advantage when feeding on Plasmodium-infected blood. Proc Natl Acad Sci U S A (2007) 1.99

5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease. FASEB J (2007) 1.97

Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2007) 1.95

Parallel developmental trajectories of sensation seeking and regular substance use in adolescents. Psychol Addict Behav (2003) 1.94

Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med (2012) 1.87

Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron (2013) 1.87

Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States. Am J Hypertens (2008) 1.86

Associations between physical activity dose and health-related quality of life. Med Sci Sports Exerc (2004) 1.86

Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.85

Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care (2007) 1.84

Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation (2009) 1.83

Relationship of satisfaction with body size and trying to lose weight in a national survey of overweight and obese women aged 40 and older, United States. Prev Med (2002) 1.83

Trends in A1C concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004. Diabetes Care (2007) 1.78

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res (2011) 1.70

Low-risk lifestyle behaviors and all-cause mortality: findings from the National Health and Nutrition Examination Survey III Mortality Study. Am J Public Health (2011) 1.68

Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci (2010) 1.66

Physical education and academic achievement in elementary school: data from the early childhood longitudinal study. Am J Public Health (2008) 1.63

PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem (2010) 1.62

Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem (2003) 1.61

A randomized study of financial incentives to increase physical activity among sedentary older adults. Prev Med (2008) 1.61

A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment. Blood (2012) 1.59

Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J Neurosci (2009) 1.59

Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study. Int J Epidemiol (2011) 1.58

Adolescent to emerging adulthood smoking trajectories: when do smoking trajectories diverge, and do they predict early adulthood nicotine dependence? Nicotine Tob Res (2007) 1.57

Effect of exercise on cognitive performance in community-dwelling older adults: review of intervention trials and recommendations for public health practice and research. J Am Geriatr Soc (2011) 1.57

Intercellular transfer of the cellular prion protein. J Biol Chem (2002) 1.54

Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity. Cancer Biol Ther (2006) 1.54

Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care (2009) 1.52

A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. Am J Pathol (2004) 1.50

The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. EMBO J (2007) 1.49

Physical activity in U.S. older adults with diabetes mellitus: prevalence and correlates of meeting physical activity recommendations. J Am Geriatr Soc (2011) 1.49

Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus. Blood (2010) 1.47

A redox switch in CopC: an intriguing copper trafficking protein that binds copper(I) and copper(II) at different sites. Proc Natl Acad Sci U S A (2003) 1.46

Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. J Biol Chem (2007) 1.44

An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives. J Neurosci (2004) 1.43

Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis (2002) 1.42

Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology (2002) 1.41

Rapid expression of chemokines and proinflammatory cytokines in newly hatched chickens infected with Salmonella enterica serovar typhimurium. Infect Immun (2004) 1.40

Disability and its correlates with chronic morbidities among U.S. adults aged 50-<65 years. Prev Med (2008) 1.39

Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages. Eur J Neurosci (2006) 1.38

Waist circumference, abdominal obesity, and depression among overweight and obese U.S. adults: National Health and Nutrition Examination Survey 2005-2006. BMC Psychiatry (2011) 1.38

MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med (2004) 1.37

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med (2003) 1.35

Identification of a novel small molecule HIF-1alpha translation inhibitor. Clin Cancer Res (2009) 1.33

Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging. J Neurosci Res (2008) 1.32

Weight loss advice U.S. obese adults receive from health care professionals. Prev Med (2008) 1.30

Genetic manipulation of intraspinal plasticity after spinal cord injury alters the severity of autonomic dysreflexia. J Neurosci (2006) 1.30

Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate (2007) 1.28

The relationships of social participation and community ratings to health and health behaviors in areas with high and low population density. Soc Sci Med (2004) 1.27

Confirmatory factor analysis of the child-feeding questionnaire among parents of adolescents. Appetite (2006) 1.27

Cell-surface prion protein interacts with glycosaminoglycans. Biochem J (2002) 1.27

Immunization delays the onset of prion disease in mice. Am J Pathol (2002) 1.26

Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res (2010) 1.26

Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol Dis (2002) 1.24

Cytokine and chemokine responses associated with clearance of a primary Salmonella enterica serovar Typhimurium infection in the chicken and in protective immunity to rechallenge. Infect Immun (2005) 1.24

Identification and functional characterization of chicken toll-like receptor 5 reveals a fundamental role in the biology of infection with Salmonella enterica serovar typhimurium. Infect Immun (2005) 1.24

Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the Doppel helix B/B' region. J Biol Chem (2004) 1.23

Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice. Am J Physiol Heart Circ Physiol (2008) 1.23

Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur J Neurosci (2006) 1.22

Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assay. J Biol Chem (2005) 1.21

Adrenergic modulation of Escherichia coli O157:H7 adherence to the colonic mucosa. Am J Physiol Gastrointest Liver Physiol (2004) 1.20

Longitudinal influence of mother's child-feeding practices on adiposity in children. J Pediatr (2006) 1.20

Physical activity or fitness and the metabolic syndrome. Expert Rev Cardiovasc Ther (2006) 1.18

Heterogeneity of normal prion protein in two- dimensional immunoblot: presence of various glycosylated and truncated forms. J Neurochem (2002) 1.18

Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US. J Diabetes (2011) 1.18

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol (2015) 1.17

Copper chelation delays the onset of prion disease. J Biol Chem (2003) 1.17

Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci (2004) 1.17

Adverse childhood experiences and smoking status in five states. Prev Med (2011) 1.17

Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation (2009) 1.16

Age, sex, and ethnic variations in serum insulin concentrations among U.S. youth: findings from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care (2006) 1.15

Solution structure of CopC: a cupredoxin-like protein involved in copper homeostasis. Structure (2002) 1.15

Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathol (2007) 1.15

Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med (2008) 1.14